Page last updated: 2024-08-18

pyridostigmine bromide and deferoxamine

pyridostigmine bromide has been researched along with deferoxamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, PT; Krishnan, K; Trobe, JD	1
Andò, S; Brancati, C; Bria, M; Caracciolo, M; De Luca, G; Lanzino, M; Le Pera, M; Maggiolini, M	1

Other Studies

2 other study(ies) available for pyridostigmine bromide and deferoxamine

Article	Year
Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine. European journal of haematology, 1995, Volume: 55, Issue:2 Topics: Adult; Anemia, Sideroblastic; Deferoxamine; Humans; Male; Myasthenia Gravis; Pyridostigmine Bromide	1995
[Measurement of the secretion of growth hormone in patients with thalassemia major]. Minerva endocrinologica, 1993, Volume: 18, Issue:3 Suppl 1 Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Dwarfism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Puberty; Pyridostigmine Bromide; Somatostatin	1993

Article

Year

Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine.

European journal of haematology, 1995, Volume: 55, Issue:2

Topics: Adult; Anemia, Sideroblastic; Deferoxamine; Humans; Male; Myasthenia Gravis; Pyridostigmine Bromide

1995

[Measurement of the secretion of growth hormone in patients with thalassemia major].

Minerva endocrinologica, 1993, Volume: 18, Issue:3 Suppl 1

Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Dwarfism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Puberty; Pyridostigmine Bromide; Somatostatin

1993